Katona É. Szubmontán erdők lágyszárú növényzetének változása tarvágás után. (1985) BOTANIKAI KÖZLEMÉNYEK 0006-8144 2415-9662 72 1-2 17-25,
1036287
Szakcikk (Folyóiratcikk) | Tudományos[1036287]
Fekete G et al. A Nemzeti Biodiverzitás-monitorozó rendszer II: A magyarországi élőhelyek leírása, határozója és a nemzeti élőhely-osztályozási rendszer. (1997)
NAGY B et al. FIBRONECTIN IN BRONCHOALVEOLAR LAVAGE FLUID AND PLASMA FROM CHILDREN WITH CHRONIC INFLAMMATION OF LUNGS. (1988) ACTA PAEDIATRICA SCANDINAVICA 0001-656X 77 5 727-733,
2767402
Szakcikk (Folyóiratcikk) | Tudományos[2767402]
XU Xiaoyan.. Granulocyte adhesion to matrix proteins and the effect on the release of granule proteins: development of a simple method and its application in experimental and clinical studies. 2001. PhD Thesis. Acta Universitatis Upsaliensis.. (2001)
MENENDEZ R et al. QUANTIFICATION OF FIBRONECTIN IN BRONCHOALVEOLAR LAVAGE FLUID AND IN LUNG PARENCHYMA - DIFFERENCES BETWEEN SMOKERS AND NONSMOKERS. (1995) RESPIRATION 0025-7931 1423-0356 62 6 312-316
ALBERA C et al. ADENOSINE-DEAMINASE ACTIVITY AND FIBRONECTIN LEVELS IN BRONCHOALVEOLAR LAVAGE FLUID IN SARCOIDOSIS AND TUBERCULOSIS. (1993) SARCOIDOSIS 0393-1447 10 1 18-25
Fachet J et al. Potentiation of nonspecific host defense by polysaccharides like lentinan - possible mechanisms. (1989) INTERNATIONAL JOURNAL OF IMMUNOTHERAPY 0255-9625 5 4 167-176,
1023458
Szakcikk (Folyóiratcikk) | Tudományos[1023458]
Korolenko T A et al. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain. (2000) DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH 0378-6501 0378-6501 26 279-283
Korolenko T A et al. Chitotriosidase as a marker of macrophage stimulation. (2000) BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE 0007-4888 1573-8221 130 948-950
Durant G et al. A SIMPLE STAINING PROCEDURE FOR THE CHARACTERIZATION OF BASIDIOMYCETES PELLETS BY IMAGE-ANALYSIS. (1994) BIOTECHNOLOGY TECHNIQUES 0951-208X 1573-6784 8 395-400
Blaschek W et al. PYTHIUM-APHANIDERMATUM - CULTURE, CELL-WALL COMPOSITION, AND ISOLATION AND STRUCTURE OF ANTITUMOR STORAGE AND SOLUBILIZED CELL-WALL (1 -] 3), (1 -] 6)-BETA-D-GLUCANS. (1992) CARBOHYDRATE RESEARCH 0008-6215 1873-426X 231 293-307
Kraus J et al. ANTITUMOR-ACTIVITY OF CELL-WALL BETA-1,3/1,6-GLUCANS FROM PHYTOPHTHORA SPECIES. (1992) PLANTA MEDICA: NATURAL PRODUCTS AND MEDICINAL PLANT RESEARCH 0032-0943 1439-0221 58 39-42
Nagy B et al. Fibronectin in Bronchoalveolar Lavage Fluid and Plasma of Dogs with Acute-Inflammation of the Lungs. (1991) APMIS 0903-4641 1600-0463 99 4 387-390,
2767343
Szakcikk (Folyóiratcikk) | Tudományos[2767343]
SZAKOS Erzsébet.. Klinikai és laboratóriumi vizsgálatok atopiás ekzema/dermatitis szindrómás Borsod-Abaúj-Zemplén megyei gyermekek körében. 2007.: [Clinical and laboratory investigations in case of children suffering from atopic eczema/dermatitis syndrome and living in Borsod-Abaúj-Zemplén County ]. (2007)
KOLBBACHOFEN V. UPTAKE OF TOXIC SILICA PARTICLES BY ISOLATED RAT-LIVER MACROPHAGES (KUPFFER CELLS) IS RECEPTOR MEDIATED AND CAN BE BLOCKED BY COMPETITION. (1992) JOURNAL OF CLINICAL INVESTIGATION 0021-9738 1558-8238 90 5 1819-1824
Nogrady N et al. Soluble cell-bound and extracellular cyclodextrin glycosyltransferases of Bacillus macerans show identical enzymological characteristics and antigenicity. (1996) JOURNAL OF BASIC MICROBIOLOGY 0233-111X 1521-4028 36 5 335-340,
1114411
Szakcikk (Folyóiratcikk) | Tudományos[1114411]
Gawande BN et al. Optimization of cyclodextrin glycosyltransferase production from Klebsiella pneumoniae AS-22 in batch, fed-batch, and continuous cultures. (2003) BIOTECHNOLOGY PROGRESS 8756-7938 1520-6033 19 6 1697-1702
Nógrády N. Development of ELISA and enzyme-linked immunofiltration assay (ELIFA) methods for monitoring cyclodextrin glycosyltransferase (CGTase) production and bacterial growth in Bacillus macerans batch cultures.. (1998) JOURNAL OF BIOTECHNOLOGY 0168-1656 1873-4863 60 1-2 15-22,
1341858
Szakcikk (Folyóiratcikk) | Tudományos[1341858]
Clauzure M et al. Disruption of interleukin-1β autocrine signaling rescues complex I activity and improves ROS levels in immortalized epithelial cells with impaired Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) function. (2014) PLOS ONE 1932-6203 9 6
Kamble R et al. Cyclodextrin glycosyltransferase production by alkaliphilic Bacillus sp. isolated from rice cultivated soil and media optimization using taguchi method. (2014) INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH 2320-5148 0975-8232 5 7 2754-2762
Wei SM et al. Epitope specificity of monoclonal and polyclonal antibodies to human elastin. (1998) INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY 1018-2438 1423-0097 115 1 33-41,
2767286
Szakcikk (Folyóiratcikk) | Tudományos[2767286]
Girotti A et al. Elastin-like recombinamers: Biosynthetic strategies and biotechnological applications. (2011) BIOTECHNOLOGY JOURNAL 1860-6768 1860-7314 6 10 1174-1186
Sallach RE et al. Long-term biostability of self-assembling protein polymers in the absence of covalent crosslinking. (2010) BIOMATERIALS 0142-9612 1878-5905 31 4 779-791
Luong E et al. Stem Cells and Scaffolds for Vascularizing Engineered Tissue Constructs. (2009) ADVANCES IN BIOCHEMICAL ENGINEERING-BIOTECHNOLOGY 0724-6145 1616-8542 114 129-172
Konova E et al. Anti-Elastin Antibodies and Elastin Turnover in Normal Pregnancy and Recurrent Pregnancy Loss. (2009) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 61 2 167-174
Maeda I et al. Immunochemical and immunohistochemical studies on distribution of elastin fibres in human atherosclerotic lesions using a polyclonal antibody to elastin-derived hexapeptide repeat. (2007) JOURNAL OF BIOCHEMISTRY 0021-924X 1756-2651 142 5 627-631
Konova E et al. Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss. (2007) JOURNAL OF AUTOIMMUNITY 0896-8411 1095-9157 28 1 46-54
Shinohara T et al. Quantitative analysis for soluble elastin in circulation and cell culture fluids using monoclonal antibody-based sandwich immunoassay. (2005) JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY 1532-1819 1532-4230 26 3 189-202
Bandiera A et al. Expression and characterization of human-elastin-repeat-based temperature-responsive protein polymers for biotechnological purposes. (2005) BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY 0885-4513 1470-8744 42 247-256
Bisaccia F et al. Solution structure of the amino acid sequence coded by the rarely expressed exon 26A of human elastin: the N-terminal region. (2000) JOURNAL OF PEPTIDE RESEARCH 1397-002X 1399-3011 1747-0277 56 4 201-209
Balogh I et al. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. (2000) BLOOD 0006-4971 1528-0020 96 7 2479-2486,
237407
Szakcikk (Folyóiratcikk) | Tudományos[237407]
Kramer Robert Anton et al. An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis. (2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 24 9
Phasha M.N. et al. Factor XIII-A Val34Leu and Tyr204Phe variants influence clot kinetics in a cohort of South African type 2 diabetes mellitus patients. (2022) GENE 0378-1119 1879-0038 834
Velickovic Jelena et al. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility. (2021) BLOOD COAGULATION & FIBRINOLYSIS 0957-5235 1473-5733 32 2 103-107
Joksic Ivana et al. COMBINED PRESENCE OF COAGULATION FACTOR XIII V34L AND PLASMINOGEN ACTIVATOR INHIBITOR 1 4G/5G GENE POLYMORPHISMS SIGNIFICANTLY CONTRIBUTE TO RECURRENT PREGNANCY LOSS IN SERBIAN POPULATION. (2020) JOURNAL OF MEDICAL BIOCHEMISTRY 1452-8258 1452-8266 39 2 199-207
Bararu Iris et al. Genomic particularities of the thrombophilic status in Type 2 diabetic patients. (2019) ROMANIAN BIOTECHNOLOGICAL LETTERS 1224-5984 2248-3942 24 5 898-905
Bezgin Tahir et al. Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study. (2018) CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS 1076-0296 1938-2723 24 1 100-106
Vishwajeet Vikarn et al. Coagulation F13A1 V34L, fibrinogen and homocysteine versus conventional risk factors in the pathogenesis of MI in young persons. (2018) ACTA CARDIOLOGICA 0001-5385 73 4 328-334
Tatarunas Vacis et al. A novel ultrasonic method for evaluation of blood clotting parameters. (2018) JOURNAL OF MEDICAL ULTRASONICS 1346-4523 1613-2254 45 4 545-553
Jadhav MA et al. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture. (2017) BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 1570-9639 1878-1454 1865 10 1246-1254
Yildirim MS et al. Prevalence of factor XIII Val34Leu polymorphism in thrombosis cases in the southeast of Turkey and its correlation with thrombosis. (2017) ACTA MEDICA MEDITERRANEA 0393-6384 2283-9720 33 1 83-87
Kim Sang-dong et al. Prevalence of the Factor XIII Val34Leu Polymorphism in Korean Patients with Deep Vein Thrombosis. (2016) ANNALS OF VASCULAR SURGERY 0890-5096 1615-5947 32 57-64
Byrnes James R et al. Newly-Recognized Roles of Factor XIII in Thrombosis. (2016) SEMINARS IN THROMBOSIS AND HEMOSTASIS 0094-6176 1098-9064 42 4 445-454
Sajjadi SM et al. Factor XIII Val34Leu polymorphism and risk of recurrent pregnancy loss in Iranian population: a case control study. (2016) FRONTIERS IN BIOLOGY 1674-7984 11 6 471-475
Duval Cedric et al. Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis. (2016) ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 1079-5642 1524-4636 36 2 308-316
Handrkova H et al. The activation peptide of coagulation factor XIII is vital for its expression and stability. (2015) JOURNAL OF THROMBOSIS AND HAEMOSTASIS 1538-7933 1538-7836 13 8 1449-1458
Walton B L et al. Fibrinogen, red blood cells, and factor XIII in venous thrombosis. (2015) JOURNAL OF THROMBOSIS AND HAEMOSTASIS 1538-7933 1538-7836 13 Suppl 1 S208-S215
Demyanenko A. V. et al. Factor XIII-A subunit Val34Leu polymorphism and risk of venous thromboembolism in young adults [ Polimorfizm val34leu a-subedinitsi faktora hsh i risk venoznogo trombojembolizma u patsientov molodogo vozrasta]. (2015) ANGIOLOGY AND VASCULAR SURGERY 1027-6661 21 2 25-36
Dickneite Gerhard et al. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions. (2015) THROMBOSIS AND HAEMOSTASIS 0340-6245 2567-689X 113 4 686-697
Alexandru Filipescu George et al. GENETIC AND BIOCHEMICAL THROMBOSIS RISK MARKERS IN PREGNANCY. I. COAGULATION PATHWAYS. (2014) ROMANIAN BIOTECHNOLOGICAL LETTERS 1224-5984 2248-3942 19 6 9940-9951
Hoppe Berthold. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation. (2014) THROMBOSIS AND HAEMOSTASIS 0340-6245 2567-689X 112 4 649-658
Wang Xuefeng et al. Association study of polymorphism of FXIIIVal34Leu gene and polycystic ovary syndrome. (2014) INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 1940-5901 7 11 4466-4470
Biswas A et al. In Vitro Secretion Deficits are Common Among Human Coagulation Factor XIII Subunit B Missense Mutants: Correlations with Patient Phenotypes and Molecular Models. (2013) HUMAN MUTATION 1059-7794 1098-1004 34 11 1490-1500
Vylliotis A et al. Effect of Thrombosis-related Gene Polymorphisms upon Oral Cancer: A Regression Analysis. (2013) ANTICANCER RESEARCH 0250-7005 1791-7530 33 9 4033-4039
Li BH et al. Lack of evidence for association between factor XIII-A Val34Leu polymorphism and ischemic stroke: A meta-analysis of 8,800 subjects. (2012) THROMBOSIS RESEARCH 0049-3848 1879-2472 130 4 654-660
Kapusta P et al. Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of disease. (2012) THROMBOSIS AND HAEMOSTASIS 0340-6245 2567-689X 108 6 1172-1179
Bagheri M et al. The Val34Leu genetic variation in the A Subunit of Coagulation Factor XIII in recurrent spontaneous abortion. (2011) SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE 1939-6368 1939-6376 57 5 261-264
Satra M et al. Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion. (2011) PHARMACOGENOMICS 1462-2416 1744-8042 12 2 195-203
Undas Anetta et al. Fibrin Clot Structure and Function : A Role in the Pathophysiology of Arterial and Venous Thromboembolic Diseases. (2011) ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 1079-5642 1524-4636 31 12 e88-e99
Jadhav MA et al. Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants. (2011) BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 1570-9639 1878-1454 1814 12 1955-1963
Jin GD et al. Coagulation Factor XIII-A Val34Leu Polymorphism and the Risk of Coronary Artery Disease and Myocardial Infarction in a Chinese Han Population. (2011) CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS 1076-0296 1938-2723 17 2 208-213
Atac FB et al. Lack of Association Between FXIII-Val34Leu, FVII-323 del/ins, and Transforming Growth Factor beta 1 (915G/T) Gene Polymorphisms and Bronchopulmonary Dysplasia: A Single-Center Study. (2010) DNA AND CELL BIOLOGY 1044-5498 1557-7430 29 1 13-18
Lopez-Cuenca A et al. Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk. (2010) ANNALS OF MEDICINE 0785-3890 1651-2219 42 8 562-575
Jadhav MA et al. Effects of Introducing Fibrinogen A alpha Character into the Factor XIII Activation Peptide Segment. (2010) BIOCHEMISTRY 0006-2960 1520-4995 49 13 2918-2924
Carreras-Torres R et al. Allele-allele interaction within the F13A1 gene: A risk factor for Ischaemic Heart Disease in Spanish population. (2010) THROMBOSIS RESEARCH 0049-3848 1879-2472 126 3 e241-e245
Kovar FM et al. The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model. (2009) WIENER KLINISCHE WOCHENSCHRIFT: MIDDLE EUROPEAN JOURNAL OF MEDICINE 0043-5325 1613-7671 121 15-16 515-519
Gohil R et al. The genetics of venous thromboembolism: A meta-analysis involving ∼120,000 cases and 180,000 controls. (2009) THROMBOSIS AND HAEMOSTASIS 0340-6245 2567-689X 102 2 360-370
Ciesla-Dul M et al. Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele. (2009) POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE 0032-3772 1897-9483 119 12 822-825
Bronic A et al. Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients. (2009) MOLECULAR BIOLOGY REPORTS 0301-4851 1573-4978 36 1 1-5
Undas A et al. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. (2009) BLOOD 0006-4971 1528-0020 114 19 4272-4278
Sturov VG et al. Structural and functional disorders in the final stage of blood clotting in patients with dysplastic syndromes. (2008) GEMATOLOGIYA I TRANSFUZIOLOGIYA 0234-5730 53 2 26-32
Leitner JM et al. Genetic variations and their influence on risk and treatment of venous thrombosis. (2008) PHARMACOGENOMICS 1462-2416 1744-8042 9 4 423-437
Mahfouz RAR et al. Factor XIII gene V34L mutation in the Lebanese population: Another unique feature in this community?. (2008) MOLECULAR BIOLOGY REPORTS 0301-4851 1573-4978 35 3 375-378
Salazar-Sanchez L et al. The FXIIIVal34Leu, common and risk factors of venous thrombosis in early middle-age Costa Rican patients. (2007) CELL BIOCHEMISTRY AND FUNCTION 0263-6484 1099-0844 25 6 739-745
Vairaktaris E et al. Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII. (2007) ONCOLOGY REPORTS 1021-335X 1791-2431 18 6 1537-1543
Sotiriadis A et al. Fibrinolytic defects and recurrent miscarriage - A systematic review and meta-analysis. (2007) OBSTETRICS AND GYNECOLOGY 0029-7844 1873-233X 109 5 1146-1155
Gal G et al. Fibrinogen A alpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. (2007) THROMBOSIS RESEARCH 0049-3848 1879-2472 121 3 333-338
Shafey Mona et al. Factor XIII Val34Leu variant and the risk of myocardial infarction. (2007) THROMBOSIS AND HAEMOSTASIS 0340-6245 2567-689X 97 4 635-641
Cushman M et al. Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis. (2007) THROMBOSIS RESEARCH 0049-3848 1879-2472 121 3 339-345
Hiltunen L et al. An unfavorable combination of factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis - a population-based nested case-control study. (2007) THROMBOSIS RESEARCH 0049-3848 1879-2472 119 4 423-432
Bouma BN et al. Thrombin activatable fibrinolysis inhibitor (TAFI) - How does thrombin regulate fibrinolysis?. (2006) ANNALS OF MEDICINE 0785-3890 38 6 378-388
Wells PS et al. The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?. (2006) BLOOD COAGULATION & FIBRINOLYSIS 0957-5235 1473-5733 17 7 533-538
Hancer VS et al. The association between factor XIII Val34Leu polymorphism and early myocardial infarction. (2006) CIRCULATION JOURNAL: OFFICIAL JOURNAL OF THE JAPANESE CIRCULATION SOCIETY 1346-9843 1347-4820 70 3 239-242
Undas A et al. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. (2006) JOURNAL OF THROMBOSIS AND HAEMOSTASIS 1538-7933 1538-7836 4 5 1029-1036
López Ramírez Y et al. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage. (2006) CLINICA CHIMICA ACTA 0009-8981 1873-3492 374 1-2 69-74
Wells PS et al. Factor XIII Val34Leu variant is protective against venous thromboembolism: A HuGE review and meta-analysis. (2006) AMERICAN JOURNAL OF EPIDEMIOLOGY 0002-9262 1476-6256 164 2 101-109
Hancer VS et al. Turkish population data on the factor XIII Val34Leu, glycoprotein (GP)Ib alpha Kozak and P-selectin glycoprotein ligand 1 (PSGL-1) loci. (2005) CELL BIOCHEMISTRY AND FUNCTION 0263-6484 1099-0844 23 1 55-58